The recall by Apotex Corp. is for Drospirenone and Ethinyl Estradiol Tablets, USP which were shipped nationwide.
“As a result of this packaging error, where a patient does not take a tablet due to a missing tablet or that a patient takes a placebo instead of an active tablet, loss of efficacy is possible due to variation in the dosage consumed,” the company said in its recall.
There have been no reports to the company of pregnancy or other adverse events, according to Apotex.
If you have one of these impacted lots, you’re advised to contact your pharmacy.
“Individuals should not interrupt their therapy, use a non-hormonal method of birth control, contact their health care provider for medical advice and may return the impacted packages to their pharmacist,” the company said.
|NDC number on outer carton||NDC Number on inner carton||Lot Number||Expiration Date||Strength||Configuration/Count|
|60505-4183-3||60505-4183-1||7DY008A||8/2020||3MG / 0.03MG||Outer Carton: Contains three inner Cartons
Inner Carton: Contains 1 blister with 21 active yellow color tablets and 7 placebo white color tablets.